Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Medicines · US (FDA)

FDA 2025

Anticholinesterases

Rivastigmine

Approved 23 Sept 2025TransdermalFilm, extended release

The FDA lists this product in 18 strengths and forms.

Official labelAsk Osler about it

On this page

Composition
Strengths and forms
Official product information

The table holds no label text for this product yet, only the facts beside it. The official product information has the full text.

Composition

Active ingredients: RIVASTIGMINE 9.5MG/24HR

Strengths and forms

The FDA lists each strength of a product separately; these pages share one label.

RIVASTIGMINE 13.3MG/24HR · Film, extended releaseANDA209063-003 · Prescription
RIVASTIGMINE 4.6MG/24HR · Film, extended releaseANDA209063-001 · Prescription
RIVASTIGMINE 9.5MG/24HR · Film, extended releaseANDA209063-002 · Prescription
RIVASTIGMINE 9.5MG/24HR · Film, extended releaseThis page
RIVASTIGMINE 13.3MG/24HR · Film, extended releaseANDA215445-003 · Prescription
RIVASTIGMINE 4.6MG/24HR · Film, extended releaseANDA215445-001 · Prescription
RIVASTIGMINE 9.5MG/24HR · Film, extended releaseANDA207308-002 · Prescription
RIVASTIGMINE 13.3MG/24HR · Film, extended releaseANDA207308-003 · Prescription
RIVASTIGMINE 4.6MG/24HR · Film, extended releaseANDA207308-001 · Prescription
RIVASTIGMINE 9.5MG/24HR · Film, extended releaseANDA205622-002 · Prescription
RIVASTIGMINE 13.3MG/24HR · Film, extended release

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

ANDA205622-003 · Prescription

RIVASTIGMINE 4.6MG/24HR · Film, extended releaseANDA205622-001 · Prescription

RIVASTIGMINE 9.5MG/24HR · Film, extended releaseANDA204403-002 · Discontinued

RIVASTIGMINE 13.3MG/24HR · Film, extended releaseANDA204403-003 · Discontinued

RIVASTIGMINE 4.6MG/24HR · Film, extended releaseANDA204403-001 · Discontinued

RIVASTIGMINE 9.5MG/24HR · Film, extended releaseANDA206318-002 · Prescription

RIVASTIGMINE 13.3MG/24HR · Film, extended releaseANDA206318-003 · Prescription

RIVASTIGMINE 4.6MG/24HR · Film, extended releaseANDA206318-001 · Prescription

Official product information

Drugs@FDA lists the approved labels, letters and reviews for application ANDA215445.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Brand name: Rivastigmine
Drug class: Anticholinesterases
Route: Transdermal
Dosage form: Film, extended release
Applicant: Yichang Humanwell
Status: Prescription
FDA approval: 23 Sept 2025
Application: ANDA215445-002
RxCUI: 183379